Progress and limitations in cancer gene therapy.

Area of Science:

• Biomedical Science
• Genetics
• Clinical Research

Background:

• Gene therapy represents a rapidly advancing field with the potential to treat genetic disorders.
• Despite progress, the translation of gene therapy into widespread clinical application faces significant hurdles.
• Understanding the limitations of current clinical trials is crucial for future development.

Purpose of the Study:

• To review the progress of gene therapy.
• To identify and discuss the limitations of current gene therapy clinical trials.
• To provide insights from the author's experience in early gene therapy research.

Main Methods:

• A comprehensive review of 464 human gene therapy trial protocols was conducted.
• Data was sourced from the U.S. National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA).
• The author's personal research and experience in gene therapy clinical trials were also discussed.

Main Results:

• The review identified key limitations in the design and execution of contemporary gene therapy clinical trials.
• Analysis of protocols revealed common challenges impacting the efficacy and safety of gene therapy interventions.
• The findings underscore the need for refined strategies in gene therapy research.

Conclusions:

• Current gene therapy clinical trials have inherent limitations that need addressing for advancement.
• Further research and protocol optimization are essential to overcome existing challenges in the field.
• The historical context of gene therapy research, including early trials, informs future directions.